Genetic testing has the potential to transform patient care. The potential of precision medicine lies in the possibility that insights from our genetic code may hold the key to preventing disease, optimizing treatments, and even living a healthier life.
Genetic testing and precision medicine companies have been moving medicine forward by contributing de-identified variant data to public health databases. By adding and maintaining high-quality genetic variants within these databases, the information can be used to ensure the quality and consensus of variant interpretation for clinical reporting and for longitudinal studies of real-world outcomes.
Collaborations among some of the world’s leading genetic testing companies and major EHR vendors including, making it easier for providers to order genetic products directly within the main patient chart, optimizing screening protocols and selected therapy based on genetic insights, etc.
The sheer volume of genomic data is staggering. The next hurdle is making sense of all that raw data in a myriad of formats. To make all this raw data usable and able to produce medical insights, they are working to solve several key challenges such as presentation of complex clinical interpretation in the EHR, integration of common ontologies, etc.
【MORE】